Faculty Bibliography

Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:segevd01

Total Results:

1087

Journal of the American College of Surgeons. 2018:227(4):S255-S255.DOI: 10.1016/j.jamcollsurg.2018.07.523

Risk Factors for a Declining Renal Function Trajectory after Living Kidney Donation [Meeting Abstract]

Holscher, Courtenay M.; Thomas, Alvin G.; Haugen, Christine E.; Jackson, Kyle R.; Wang, Jacqueline Garonzik; Massie, Allan B.; Segev, Dorry L.
ISI:000447760600506
ISSN: 1072-7515
CID: 5132512
Journal of the American College of Surgeons. 2018:227(4):S255-S256.DOI: 10.1016/j.jamcollsurg.2018.07.524

Turn Down for What: Outcomes Associated with Declining an Older Liver Donor [Meeting Abstract]

Haugen, Christine E.; Holscher, Courtenay M.; Bowing, Mary Grace; Cameron, Andrew M.; Philosophe, Benjamin; McAdams-DeMarco, Mara; Segev, Dorry L.; Garonzik-Wang, Jacqueline M.
ISI:000447760600507
ISSN: 1072-7515
CID: 5132522
American journal of transplantation. 2018:18(SI):524-524.DOI:

Delayed Graft Function in Live Donor HLA-Incompatible Kidney Transplant Recipients: A Multicenter Study. [Meeting Abstract]

Motter, J.; Massie, A.; Wang, J. Garonzik; Jackson, K.; Luo, X.; Muzaale, A.; Orandi, B.; Segev, D.
ISI:000431965402145
ISSN: 1600-6135
CID: 5520742
American journal of transplantation. 2018:18(SI):34-35.DOI:

Impact of the Number of Simultaneous Offers on Kidney Delay and Discard [Meeting Abstract]

Mankowski, Michal; Raghavan, S.; Holscher, Courtenay; Kosztowski, Martin; Segev, Dorry; Gentry, Sommer
ISI:000419034500047
ISSN: 1600-6135
CID: 5456142
American journal of transplantation. 2018:18(SI):468-468.DOI:

Hospital Readmissions Following ABO-Incompatible Live Donor Kidney Transplantation: A National Study. [Meeting Abstract]

Orandi, B.; Luo, X.; Bae, S.; King, E.; Garonzik-Wang, J.; Segev, D.
ISI:000431965401579
ISSN: 1600-6135
CID: 5520732
American journal of transplantation. 2018:18(SI):367-368.DOI:

Population-Based Modeling of Prototypes and Determinants of Allograft Function Trajectories after Kidney Transplantation: Implications for Patient Monitoring and Risk Stratification. [Meeting Abstract]

Raynaud, M.; Aubert, O.; Naessens, M.; Morelon, E.; Giral, M.; Kamar, N.; Wong, E.; Jordan, S.; Orandi, B.; Segev, D.; Stegal, M.; Reese, P.; Lefaucheur, C.; Loupy, A.
ISI:000431965401317
ISSN: 1600-6135
CID: 5520722
American journal of transplantation. 2018:18(SI):48-49.DOI:

Hospital Readmissions Following ABO-Incompatible Kidney Transplantation: A National Study [Meeting Abstract]

Orandi, B.; Luo, X.; Bae, S.; King, E.; Garonzik-Wang, J.; Segev, D.
ISI:000419034500072
ISSN: 1600-6135
CID: 5520702
American journal of transplantation. 2018:18(SI):55-56.DOI:

Delayed Graft Function in Live Donor HLA-Incompatible Kidney Transplant Recipients: A Multicenter Study [Meeting Abstract]

Motter, Jennifer; Massie, Allan; Garonzik-Wang, Jacqueline; Jackson, Kyle; Muzaale, Abimereki; Orandi, Babak; Segev, Dorry
ISI:000419034500096
ISSN: 1600-6135
CID: 5520712
American journal of transplantation. 2018:18(SI):411-412.DOI:

Estimated Impact of the Number of Simultaneous Offers on Kidney Delay and Discard. [Meeting Abstract]

Mankowski, M.; Raghavan, S.; Holscher, C.; Kosztowski, M.; Segev, D.; Gentry, S.
ISI:000431965401427
ISSN: 1600-6135
CID: 5486572
American journal of transplantation. 2017:17(12):3123-3130.DOI: 10.1111/ajt.14392

The incremental cost of Incompatible Living Donor Kidney Transplant: A National Cohort Analysis

Axelrod, David; Lentine, Krista L; Schnitzler, Mark A; Luo, Xun; Xiao, Huiling; Orandi, Babak J; Massie, Allan; Garonzik-Wang, Jacqueline; Stegall, Mark D; Jordan, Stanley C; Oberholzer, Jose; Dunn, Ty B; Ratner, Lloyd E; Kapur, Sandip; Pelletier, Ronald P; Roberts, John P; Melcher, Marc L; Singh, Pooja; Sudan, Debra L; Posner, Marc P; El-Amm, Jose M; Shapiro, Ron; Cooper, Matthew; Lipkowitz, George S; Rees, Michael A; Marsh, Christopher L; Sankari, Bashir R; Gerber, David A; Nelson, Paul W; Wellen, Jason; Bozorgzadeh, Adel; Gaber, A Osama; Montgomery, Robert A; Segev, Dorry L
Incompatible living donor kidney transplant (ILDKT) has been established as an effective option for end stage renal disease (ESRD) patients with willing but HLA incompatible live donors, reducing mortality and improving quality of life. Depending upon antibody titer, ILDKT can require highly resource intensive procedure including intravenous immunoglobulin, plasma exchange and/or cell depleting antibody treatment as well as protocol biopsies and DSA testing. This study sought to compare the cost and Medicare reimbursement, exclusive of organ acquisition payment, for ILDKT recipients (N=926) with varying antibody titers to matched compatible transplants (N=2762) performed between 2002-2011. Data were assembled from a national cohort study of ILDKT and a unique dataset linking hospital cost accounting data, and Medicare claims. Overall, ILDKT transplants were 41% more expensive than their compatible counterparts ($151,024 vs. $106,636, p<.0001). The incremental cost varied by antibody titers: positive on Luminex assay but negative flow cytometric crossmatch 20% increase, positive flow cytometric crossmatch but negative cytotoxic crossmatch 26% increase, and positive cytotoxic crossmatch 39% increase (p<.0001 for all). ILDKT was associated with higher Medicare payments ($91,330 vs. $63,782 p<.0001), longer median length of stay (12.9 vs. 7.8 days), and greater outlier payments. In conclusion, ILDKT increases the cost of and payments for kidney transplant
PMID: 28613436
ISSN: 1600-6143
CID: 2595102